A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.

By M. Elkins, M. Robinson, B. Rose, C. Harbour, C. Moriarty, G. Marks, E. Belousova, W. Xuan, P. Bye. New England Journal of Medicine, 2006

826 citations recorded by the source corpus.

Subfields: Physiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/f79d8450bcbcfefa4dfe4bd68ce3b2d81d91ae7d

Citations in the corpus

• Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. (2007, neutral): “The largest trial investigated the effect of twice daily treatments with 7% saline for 48 weeks in 164 patients (34), while the others involved fewer patients and shorter treatment durations (2-12 weeks).”
• A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation (2011, neutral): “New England Journal of Medicine, 365(18), 1663-1672.”